PMID- 37871272 OWN - NLM STAT- MEDLINE DCOM- 20231101 LR - 20231127 IS - 1539-2864 (Electronic) IS - 0275-004X (Linking) VI - 43 IP - 11 DP - 2023 Nov 1 TI - INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE. PG - 1928-1935 LID - 10.1097/IAE.0000000000003883 [doi] AB - PURPOSE: To determine the effect of combined macular spectral-domain optical coherence tomography (SD-OCT) and ultrawide field retinal imaging (UWFI) within a telemedicine program. METHODS: Comparative cohort study of consecutive patients with both UWFI and SD-OCT. Ultrawide field retinal imaging and SD-OOCT were independently evaluated for diabetic macular edema (DME) and nondiabetic macular abnormality. Sensitivity and specificity were calculated with SD-OCT as the gold standard. RESULTS: Four hundred twenty-two eyes from 211 diabetic patients were evaluated. Diabetic macular edema severity by UWFI was as follows: no DME 93.4%, noncenter involved DME (nonciDME) 5.1%, ciDME 0.7%, ungradable DME 0.7%. SD-OCT was ungradable in 0.5%. Macular abnormality was identified in 34 (8.1%) eyes by UWFI and in 44 (10.4%) eyes by SD-OCT. Diabetic macular edema represented only 38.6% of referable macular abnormality identified by SD-OCT imaging. Sensitivity/specificity of UWFI compared with SD-OCT was 59%/96% for DME and 33%/99% for ciDME. Sensitivity/specificity of UWFI compared with SDOCT was 3%/98% for epiretinal membrane. CONCLUSION: Addition of SD-OCT increased the identification of macular abnormality by 29.4%. More than 58.3% of the eyes believed to have any DME on UWF imaging alone were false-positives by SD-OCT. The integration of SD-OCT with UWFI markedly increased detection and reduced false-positive assessments of DME and macular abnormality in a teleophthalmology program. FAU - Aiello, Lloyd Paul AU - Aiello LP AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. AD - Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. FAU - Jacoba, Cris Martin P AU - Jacoba CMP AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. FAU - Ashraf, Mohamed AU - Ashraf M AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. AD - Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. FAU - Cavallerano, Jerry D AU - Cavallerano JD AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. AD - Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. FAU - Tolson, Ann M AU - Tolson AM AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. FAU - Tolls, Dorothy AU - Tolls D AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. FAU - Sun, Jennifer K AU - Sun JK AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. AD - Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. FAU - Silva, Paolo S AU - Silva PS AUID- ORCID: 0000-0001-8024-9348 AD - Joslin Diabetes Center, Beetham Eye Institute, Boston, Massachusetts; and. AD - Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. LA - eng GR - Massachusetts Lions Eye Research Fund/ PT - Journal Article PL - United States TA - Retina JT - Retina (Philadelphia, Pa.) JID - 8309919 SB - IM MH - Humans MH - *Diabetic Retinopathy/diagnosis MH - Tomography, Optical Coherence/methods MH - *Macular Edema/diagnostic imaging MH - Cohort Studies MH - *Telemedicine MH - *Ophthalmology MH - Retrospective Studies MH - *Diabetes Mellitus EDAT- 2023/10/23 18:42 MHDA- 2023/11/01 12:43 CRDT- 2023/10/23 16:06 PHST- 2023/11/01 12:43 [medline] PHST- 2023/10/23 18:42 [pubmed] PHST- 2023/10/23 16:06 [entrez] AID - 00006982-202311000-00012 [pii] AID - 10.1097/IAE.0000000000003883 [doi] PST - ppublish SO - Retina. 2023 Nov 1;43(11):1928-1935. doi: 10.1097/IAE.0000000000003883.